EP0875571A3 - CRFG-1, Ziel und Marker für chronisches Nierenversagen - Google Patents

CRFG-1, Ziel und Marker für chronisches Nierenversagen Download PDF

Info

Publication number
EP0875571A3
EP0875571A3 EP98303237A EP98303237A EP0875571A3 EP 0875571 A3 EP0875571 A3 EP 0875571A3 EP 98303237 A EP98303237 A EP 98303237A EP 98303237 A EP98303237 A EP 98303237A EP 0875571 A3 EP0875571 A3 EP 0875571A3
Authority
EP
European Patent Office
Prior art keywords
renal failure
chronic renal
crfg
marker
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98303237A
Other languages
English (en)
French (fr)
Other versions
EP0875571A2 (de
Inventor
Nicholas SmithKline Beecham Pharm. Laping
Barbara SmithKline Beecham Pharm. Olson
Yuan SmithKline Beecham Pharm. Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0875571A2 publication Critical patent/EP0875571A2/de
Publication of EP0875571A3 publication Critical patent/EP0875571A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP98303237A 1997-04-30 1998-04-27 CRFG-1, Ziel und Marker für chronisches Nierenversagen Withdrawn EP0875571A3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4520397P 1997-04-30 1997-04-30
US45203P 1997-04-30
US98802897A 1997-12-10 1997-12-10
US988028 1997-12-10

Publications (2)

Publication Number Publication Date
EP0875571A2 EP0875571A2 (de) 1998-11-04
EP0875571A3 true EP0875571A3 (de) 2000-08-23

Family

ID=26722490

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98303237A Withdrawn EP0875571A3 (de) 1997-04-30 1998-04-27 CRFG-1, Ziel und Marker für chronisches Nierenversagen

Country Status (3)

Country Link
EP (1) EP0875571A3 (de)
JP (2) JPH1132785A (de)
CA (1) CA2228742A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263072B2 (en) 2007-06-22 2012-09-11 Genera Istrazivanja, d.o.o. ADAMTS4 as a blood biomarker and therapeutic target for chronic renal failure
CN106043642B (zh) * 2016-05-30 2018-08-21 深圳市鼎盛智能科技有限公司 一种机器人仿生机构及机器人

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018225A1 (en) * 1993-12-24 1995-07-06 Medical Research Council Polycystic kidney disease 1 gene and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018225A1 (en) * 1993-12-24 1995-07-06 Medical Research Council Polycystic kidney disease 1 gene and uses thereof

Also Published As

Publication number Publication date
CA2228742A1 (en) 1998-10-30
EP0875571A2 (de) 1998-11-04
JP2002223778A (ja) 2002-08-13
JPH1132785A (ja) 1999-02-09

Similar Documents

Publication Publication Date Title
WO1998031799A3 (en) Polynucleotides and polypeptides encoding receptors
EP1001023A3 (de) Frizzled-4, ein möglicher Wnt-Rezeptor
EP0939124A3 (de) MBGP1-Sequenzen
ITVI970167A0 (it) Struttura di copertura del posto di guida di macchine operatrici.
EP0875572A3 (de) CRFG-1a, Ziel und Marker für chronisches Nierenversagen
EP2264174A3 (de) Protein, das mit einem Neuroendokrinspezifischen Protein änhelt, und dafür kodierende cDNS
EP0887081A3 (de) Humäne Serumglucocorticoidregulierte Kinase, ein Ziel für chronischer Nierenerkrankung
EP0911399A3 (de) HTHBZ47, ein Kringle verwandter Klon
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
WO1999035266A3 (en) Human urotensin ii
EP0875573A3 (de) CRFG-1b, Ziel und Marker für chronisches Nierenversagen
EP0943684A3 (de) Frizzled-ähnliche Polypeptide und Polynukleotide
EP0875577A3 (de) Gen der Membrantyp-Matrix-Metalloproteinase-5
WO2001083744A3 (en) Natrium-calcium exchanger protein
EP0897982A3 (de) Natiumbikarbonat Kotransporter
WO1999011783A3 (en) T-box polypeptides
EP0911391A3 (de) Klon HWHHJ20
EP0937777A3 (de) GABA Rezeporen und deren Anwendungen
EP0890646A3 (de) Serine-Protease HE2NW40
EP0887415A3 (de) Menschliches RCE1
EP0913472A3 (de) Humanes LIG-1 Homologes (HLIG-1)
WO1998042833A3 (en) Kv potassium channel polypeptides and polynucleotides
EP0897009A3 (de) HKABY60 Polypeptide
EP0939123A3 (de) Mit den Östrogenrezeptor verwandten Polypeptid SBPERR4
EP0875570A3 (de) Neurodegenerative Polypeptide HHPDZ65

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE CH DE DK FR GB IT LI NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20010223

AKX Designation fees paid

Free format text: BE CH DE DK FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20020923